Key result
Concurrent operations were not significantly associated with an increased risk of death or serious morbidity compared to non-concurrent operations after risk adjustment (OR 1.08; 95% CI 0.96-1.21).
Why the study?
Do concurrent operations increase the risk of death, serious morbidity, reoperation, or readmission in surgical patients?
Cohort
Yes
Do concurrent operations increase the risk of death, serious morbidity, reoperation, or readmission in surgical patients?
Effect estimate: OR 1.08 (95% CI 0.96-1.21)
Absolute Event Rate: 9% vs 7.1%
Concurrent operations were not associated with an increased risk of death, serious morbidity, unplanned reoperation, or unplanned readmission after risk adjustment.
Concurrent operations not linked to higher risk after adjustment; hypothesis-generating and should not yet change surgical scheduling practices.
OBJECTIVE: To determine whether concurrently performed operations are associated with an increased risk for adverse events. BACKGROUND: Concurrent operations occur when a surgeon is simultaneously responsible for critical portions of 2 or more operations. How this practice affects patient outcomes is unknown. METHODS: Using American College of Surgeons' National Surgical Quality Improvement Program data from 2014 to 2015, operations were considered concurrent if they overlapped by ≥60 minutes or in their entirety. Propensity-score-matched cohorts were constructed to compare death or serious morbidity (DSM), unplanned reoperation, and unplanned readmission in concurrent versus non-concurrent operations. Multilevel hierarchical regression was used to account for the clustered nature of the data while controlling for procedure and case mix. RESULTS: There were 1430 (32.3%) surgeons from 390 (77.7%) hospitals who performed 12,010 (2.3%) concurrent operations. Plastic surgery (n = 393 [13.7%]), otolaryngology (n = 470 [11.2%]), and neurosurgery (n = 2067 [8.4%]) were specialties with the highest proportion of concurrent operations. Spine procedures were the most frequent concurrent procedures overall (n = 2059/12,010 [17.1%]). Unadjusted rates of DSM (9.0% vs 7.1%; P < 0.001), reoperation (3.6% vs 2.7%; P < 0.001), and readmission (6.9% vs 5.1%; P < 0.001) were greater in the concurrent operation cohort versus the non-concurrent. After propensity score matching and risk-adjustment, there was no significant association of concurrence with DSM (odds ratio [OR] 1.08; 95% confidence interval [CI] 0.96-1.21), reoperation (OR 1.16; 95% CI 0.96-1.40), or readmission (OR 1.14; 95% CI 0.99-1.29). CONCLUSIONS: In these analyses, concurrent operations were not detected to increase the risk for adverse outcomes. These results do not lessen the need for further studies, continuous self-regulation and proactive disclosure to patients.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2017) conducted a cohort in Surgical procedures. Concurrent operations vs. Non-concurrent operations was evaluated on Death or serious morbidity (DSM) (OR 1.08, 95% CI 0.96-1.21). Concurrent operations were not significantly associated with an increased risk of death or serious morbidity compared to non-concurrent operations after risk adjustment (OR 1.08; 95% CI 0.96-1.21).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: